Page last updated: 2024-08-16

resorcinol and rifampin

resorcinol has been researched along with rifampin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Abdel-Wahab, H; Abdelghani, R; Agut-Busquet, E; Becherel, PA; Beksaç, B; Benhadou, F; Bettoli, V; Bouazzi, D; Calamo, G; Del Marmol, V; Delage-Toriel, M; Dolenc-Voljc, M; Doss, N; El-Domyati, M; Emtestam, L; Fatani, M; Glowaczewska, A; Guillem, P; Gürer, MA; Hlela, C; Jemec, GBE; Kappe, NN; Kottb, HR; Lam, TTH; Lapins, J; Matusiak, L; Moftah, N; Nassif, A; Pascual, JC; Prens, EP; Riis, PT; Romaní, J; Saunte, DM; Sigsgaard, V; Szepietowski, JC; Theiler, M; van den Worm, L; van der Zee, HH; Vanlaerhoven, AMJD; Villani, AP; Weibel, L1

Other Studies

2 other study(ies) available for resorcinol and rifampin

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
    Archives of dermatological research, 2020, Volume: 312, Issue:10

    Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; Body Mass Index; Child; Clindamycin; Comorbidity; Cross-Sectional Studies; Dermatologic Surgical Procedures; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Hirsutism; Humans; Male; Obesity; Pilonidal Sinus; Resorcinols; Rifampin; Risk Factors; Severity of Illness Index; Smoking; Tetracycline; Treatment Outcome; Young Adult

2020